Merck
MRK
#63
Rank
NZ$425.27 B
Marketcap
NZ$170.26
Share price
-1.98%
Change (1 day)
0.40%
Change (1 year)

EPS for Merck (MRK)

EPS in 2025 (TTM): NZ$13.10

According to Merck's latest financial reports the company's current EPS (TTM) is NZ$13.16. In 2024 the company made an earnings per share (EPS) of NZ$11.71 an increase over its 2023 EPS that were of NZ$0.27.

EPS history for Merck from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ$13.1011.87%
2024NZ$11.714308.46%
2023NZ$0.27-97.32%
2022NZ$9.9310.92%
2021NZ$8.9584.68%
2020NZ$4.85-27.2%
2019NZ$6.6663.44%
2018NZ$4.07151.11%
2017NZ$1.62-54.58%
2016NZ$3.5730.21%
2015NZ$2.74-61.99%
2014NZ$7.21180.51%
2013NZ$2.57-31.82%
2012NZ$3.776.62%
2011NZ$3.54

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
NZ$2.98-77.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$18.09 37.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$35.55 170.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$5.15-60.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$6.42-51.20%๐Ÿ‡ซ๐Ÿ‡ท France
GlaxoSmithKline
GSK
NZ$6.23-52.65%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
NZ$1.09-91.70%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Novartis
NVS
NZ$12.75-3.08%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Abbott Laboratories
ABT
NZ$13.96 6.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$22.58 71.59%๐Ÿ‡บ๐Ÿ‡ธ USA